Anticancer agent 269

Anticancer agent 269 (Compound 11c) is an orally active caspase-3 activator that promotes ROS generation by activating caspase-3, induces cancer cell apoptosis (Apoptosis), and exhibits significant anticancer activity. It can be used for research in the field of cancer[1].

Product Specifications

UNSPSC

12352005

Target

Apoptosis; Caspase; Reactive Oxygen Species (ROS)

Related Pathways

Apoptosis; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB

Field of Research

Cancer

Smiles

ClC1=CC=C(C2=NOC(C3=CC=C(C)C4=C3[Se]N=N4)(C)C2)C=C1

Molecular Formula

C17H14ClN3OSe

Molecular Weight

390.73

References & Citations

[1]Enneiymy M, et al. In-Silico Analysis of Benzo-Selenadiazole Hybrids: Reactivity and Anticancer Potential Assessed Through DFT, Molecular Dynamics, Molecular Docking, and ADMET[J]. Polycyclic Aromatic Compounds, 2025: 1-23.